INS and metabolic dysfunction-associated steatohepatitis: In summary, we have provided a resource describing the changes in hepatokine secretion in NASH and a deeper appreciation of potential endocrine circuits that mediate NASH comorbidities such as defective lipid metabolism and insulin action.